CeriBell, Inc. (CBLL)
NASDAQ: CBLL · Real-Time Price · USD
15.62
-0.18 (-1.14%)
Jul 17, 2025, 4:00 PM - Market closed

Company Description

CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.

The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting.

It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders to record and store EEG signals generated by the headband.

In addition, the company provides Clarity, an AI-powered seizure detection algorithm. Further, it operates Ceribell EEG portal, a cloud-based secured portal that enables real-time remote access to a patient’s EEG data.

The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015.

CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

CeriBell, Inc.
CeriBell logo
CountryUnited States
Founded2014
IPO DateOct 11, 2024
IndustryMedical Devices
SectorHealthcare
Employees281
CEOXingjuan Chao

Contact Details

Address:
360 North Pastoria Avenue
Sunnyvale, California 94085
United States
Phone(800) 436-0826
Websiteceribell.com

Stock Details

Ticker SymbolCBLL
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$17.00
CIK Code0001861107
ISIN NumberUS15678C1027
Employer ID47-1785452
SIC Code3845

Key Executives

NamePosition
Dr. Xingjuan Chao Ph.D.Co-Founder, President, Chief Executive Officer and Director
Dr. Josef Parvizi M.D., Ph.D.Co-Founder, Chief Medical Advisor and Director
Scott BlumbergChief Financial Officer
Dr. Raymond Woo Ph.D.Chief Technology Officer
Dan RogySenior Vice President of Operations
Louisa Daniels J.D., M.B.A.General Counsel
Sean ManniSenior Vice President of Sales
Brian P. PriceSenior Vice President of Marketing
Kristie RodenbushChief People Officer
Baharan Kamousi Ph.D.Senior Vice President of Data Science

Latest SEC Filings

DateTypeTitle
Jul 7, 20258-KCurrent Report
Jul 7, 2025144Filing
Jun 20, 20258-KCurrent Report
Jun 18, 2025144Filing
Jun 17, 2025144Filing
Jun 16, 2025144Filing
Jun 13, 2025144Filing
Jun 12, 20258-KCurrent Report
Jun 9, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Jun 3, 2025144Filing